Postoperative adjuvant randomised trial comparing chemoendocrine therapy, chemotherapy and immunotherapy for patients with stage II breast cancer: 5-year results from the nishinihon cooperative study group of adjuvant chemoendocrine therapy for breast cancer (ACETBC) of Japan
- 29 February 1996
- journal article
- clinical trial
- Published by Elsevier BV in European Journal of Cancer
- Vol. 32 (2), 235-242
- https://doi.org/10.1016/0959-8049(95)00579-x
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Efficacy of immunochemotherapy as adjuvant treatment after curative resection of gastric cancerThe Lancet, 1994
- Randomized, controlled study on adjuvant immunochemotherapy with PSK® in curatively resected colorectal cancerDiseases of the Colon & Rectum, 1992
- Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy: 133 randomised trials involving 31 000 recurrences and 24 000 deaths among 75 000 womenThe Lancet, 1992
- Endocrineversus endocrine plus five-drug chemotherapy in postmenopausal women with stage II estrogen receptor-positive breast cancerCancer, 1989
- The general rules for clinical and pathological recording of breast cancerSurgery Today, 1989
- Adjuvant Chemo-Endocrine Therapy or Endocrine Therapy Alone for Postmenopausal Patients: Ludwig Studies III and IVRecent Results in Cancer Research, 1989
- Krestin (PSK)Cancer Treatment Reviews, 1984
- Surgical adjuvant chemotherapy with mitomycin C and cyclophosphamide in Japanese patients with breast cancerCancer, 1980